Evaluation of an Intensified Systematic Screening for Congenital Hypothyroidism in Premature Newborns
Starting soon
Conditions studied: Congenital Hypothyroidism
In brief
Currently in France, screening for congenital hypothyroidism (CH) in premature infants is done by a single TSH assay on filter paper. However, European recommendations advise repeating the assay within the first month of life. Our primary objective is to estimate the incidence of CH in preterm infants under 32 weeks of gestational age by applying the European recommendations.
Key facts
- Study ID
- NCT07425028
- Run by
- University Hospital, Lille
- People needed
- 1600
- Starts
- 2027-03-01
- Expected to finish
- 2028-03-01
- Last updated by the study team
- 2026-05-22
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Newborns born prematurely between 23 and 32 weeks of gestational age (up to 31 weeks and 6 days), both female and male, of all ethnic origins, regardless of birth weight, and including all other pathologies.
- Newborns whose parents have given their non-opposition consent.
You may not qualify if…
- Newborns born who leave the region before day 15.
- Newborns who die before 15 days of age.
- Newborns whose parents are not affiliated with the social security system.
Where it is running
- Chu de Lille — Lille, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.